Cargando…
Inhibition of NOS1 promotes the interferon response of melanoma cells
BACKGROUND: NOS1 expression predicts poor prognosis in patients with melanoma. However, the molecular function of NOS1 in the type I IFN response and immune escape of melanoma is still unknown. METHODS: The CRISPR/Cas9 system was used to generate NOS1-knockout melanoma cells and the biological chara...
Autores principales: | Chen, Xi, Zou, Zhiwei, Wang, Qianli, Gao, Wenwen, Zeng, Sisi, Ye, Shuangyan, Xu, Pengfei, Huang, Mengqiu, Li, Keyi, Chen, Jianping, Zhong, Zhuo, Zhang, Qianbing, Hao, Bingtao, Liu, Qiuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092760/ https://www.ncbi.nlm.nih.gov/pubmed/35538490 http://dx.doi.org/10.1186/s12967-022-03403-w |
Ejemplares similares
-
NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2
por: Xu, Pengfei, et al.
Publicado: (2019) -
The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism
por: Ye, Shuangyan, et al.
Publicado: (2020) -
NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
por: Zhu, Lingqun, et al.
Publicado: (2017) -
Publisher Correction: NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
por: Zhu, Lingqun, et al.
Publicado: (2019) -
The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells
por: Gao, Wenwen, et al.
Publicado: (2021)